top of page
Briefing paper on Access to Orphan Medicines in the UK
On 5th June 2014, Cancer52 published its Briefing Paper on Access to Orphan Medicines in the UK.
Clara Mackay appointed as interim chair of Cancer52
Cancer52 is delighted to announce that Clara Mackay, Deputy CEO of Pancreatic Cancer UK, has been appointed as interim chair of Cancer52....
NICE consultation on Technology Appraisals Process Guide
On the basis of the increasing experience of our members with NICE Technology Appraisals Cancer52 has commented in detail on a number of...
Cancer52 responds to NICE consultation on Technology Appraisals Process Guide
On the basis of the increasing experience of our members with NICE Technology Appraisals Cancer52 has commented in detail on a number of...
Briefing paper on the UK Strategy for Rare Diseases: Making sure that rare cancers aren’t written ou
On 24th February 2014, Cancer52 published its Briefing Paper on the UK Strategy for Rare Diseases.
Cancer52 publishes briefing paper on the UK Strategy for Rare Diseases
Making sure that rare cancers aren’t written out of the script Cancer52 published its briefing paper on the UK Strategy for Rare...
Briefing paper on NICE and Value Based Assessment (VBA)
On 21st February 2014, Cancer52 published its Briefing Paper "VBA: NICE do it their way".
Cancer52 publishes briefing paper on NICE and Value Based Assessment (VBA)
Cancer52 published its briefing paper "NICE and Value Based Assessment (VBA) - NICE do it their way." NICE is due to consult on its...
NCRI and Cancer52 publish report on research spend
The National Cancer Research Institute (NCRI) and Cancer52 have published a report "Research into less common cancers". It shows for the...
Cancer52 welcomes NCIN Routes to Diagnosis research
The National Cancer Intelligence Network (NCIN) has published new research on Routes to Diagnosis (RtD) for 55 cancer sites or groups,...
bottom of page